2561 — Visen Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Visen Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	HKAS	HKAS	HKAS
Status:	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	626	348	204
Net Total Receivables	70.6	13.5	9.57
Prepaid Expenses
Total Other Current Assets
Total Current Assets	712	374	223
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.2	13.3	11.2
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	741	444	294
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	87.3	51.8	52.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	88.7	52.9	52.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	653	391	241
Total Liabilities & Shareholders' Equity	741	444	294
Total Common Shares Outstanding